Our latest CPD options for you: Injectables for weight loss WEBINAR 7 July, 7.30pm. Jeremy Krebs on initiating and managing injectable therapies, focusing on contraindications, dose titration, maintenance dosing and intolerance management. Register here Managing lumbar and cervical spine presentations WEBINAR 14 July, 7.30pm. Otis Shirley will outline a practical primary care approach to common lumbar and cervical spine presentations, including recognising key pathologies,

This year's online Primary Care Update Day on Saturday 5 September, brings together 13 experts to discuss what's been happening for primary care, including: Psychedelic medicines in New Zealand: David Menkes outlines potential benefits, the current situation in Aotearoa New Zealand, and what's required to guide safe, effective practice. Restless Leg Syndrome: Alex Bartle provides a clear, current approach to managing a condition that can have a major impact on sleep, mood and

Notice of HbA1c diagnostic threshold changes in brief1,2: New HbA1c criteria define normal as under 42 mmol/mol, prediabetes as 42-47, and diabetes as 48 or higher; no confirmation is needed if HbA1c is 53 mmol/mol or above. Vildagliptin should not be added to dulaglutide, as both act on GLP‑1 pathways. In pregnancy, all diabetes medications, including ACE inhibitors and statins, are stopped, with only metformin and insulin used, and all pregnant women require secondary ca

Dear Andrea, Our latest CPD options for you: Sepsis, and Managing respiratory viral infections WEBINAR 30 June: Paul Huggan on sepsis management and Tim Cutfield on the management of common respiratory viral infections. Register here Injectables for weight loss WEBINAR 7 July, 7.30pm. Jeremy Krebs on initiating and managing injectable therapies, focusing on contraindications, dose titration, maintenance dosing and intolerance management. Register here Managing lumb

Keep Saturday 5 September free. This year's online Update Day from the Goodfellow Unit brings you 13 experts to discuss what's been happening in paediatrics, prescribing, mental health, and so much more.The 2026 Primary Care Update webinar day includes: A day of practice-changing New Zealand-specific updates. 6 CPD hours (RNZCGP) and 6 professional development hours endorsed by the College of Nurses Aotearoa (NZ). Ongoing access to online archives of the recordings. This full

Our latest CPD options for you: Chronic kidney disease, hyperuricaemia and gout - when to treat? WEBINAR 9 June: Rob Walker and Hannah Giles on how to manage patients when chronic kidney disease, hyperuricaemia, and gout coexist. Register here Metabolic Soup WEBINAR 16 June: Ryan Paul gives practical, evidence-based strategies for managing diabetes, dyslipidaemia, hypertension, gout, and kidney disease, with an emphasis on simplifying and integrating care across these in

Evidence from randomised trials on optimal LDL cholesterol targets for secondary prevention in known atherosclerotic cardiovascular disease is limited. In an open trial, 3048 patients with known CVD disease were randomised to an LDL target of below 1.4 mmol/L or below 1.8 mmol/L.1 The primary outcome was a composite of cardiovascular death, nonfatal myocardial infarction or stroke, revascularisation, or hospitalisation for unstable angina over 3 years. The median achieved LDL

Continuing Professional Development Podcasts | Webinars | Gems | eLearning | MedCases Our latest selection of CPD options for you: Lipids, BP, and the metabolic syndrome puzzle WEBINAR 26 May: Consultant Cardiologist Gerry Wilkins on taming the trio: Lipids, BP, and the Metabolic Syndrome. Register here Management of Diabetes and CHF WEBINAR 2 June: Ryan Paul overviews a practical approach to best practice of heart failure in people with diabetes, including the rol

Macrolides were evaluated using individual patient-level data on asthma control, as well as on severe exacerbations and harms1. Evidence certainty followed GRADE. Across 19 trials (1825 patients), macrolides improved asthma control 40.6% vs placebo (21.6%); achieved a ≥ 0.5-point improvement (high certainty); likely reduced severe exacerbations (incidence rate ratio 0.75; moderate certainty); and modestly improved quality of life. Serious adverse events and mortality showed

Enhance your Dermatology Expertise: Join Our Online Session this Saturday, 16 May. Join leading New Zealand dermatology specialists in this 4-hour webinar designed to help you navigate complex cases with confidence. All registrants will enjoy continued access to the full video recording, so you won’t miss a moment - even if you can’t attend live on Saturday. Enhance your Dermatology Expertise: Join Our Online Session this Saturday, 16 May.Join leading New Zealand dermatolo

Our latest selection of CPD options for you: High-risk cutaneous squamous cell carcinoma (cSCC) WEBINAR 12 May: Rajan Patel discusses the importance of early detection and timely management of high-risk cSCC. Register here Lipids, BP, and the metabolic syndrome puzzle WEBINAR 26 May: Consultant Cardiologist Gerry Wilkins on taming the trio: Lipids, BP, and the Metabolic Syndrome. Register here Management of Diabetes and CHF WEBINAR 2 June: Ryan Paul overviews a practical

Accurately diagnosing and treating impetigo and intertrigo in infants is important because their skin barrier is immature, infections spread faster, and complications can escalate before anyone realises what’s happening. In her talk at the Practical Update day, Specialist Dermatologist Lisa Connelly will focus on the diagnosis and management of impetigo and intertrigo (cradle cap) in children while also distinguishing these conditions from atopic eczema. She will also discuss

Early identification of AAS in younger Māori This study examined ethnic disparities in acute aortic syndrome (AAS) in Midland region patients1. Researchers conducted a 10-year retrospective review (2010–2020) of 250 consecutive AAS cases, in which Māori made up 23.3% of the population. Outcomes were compared between Māori and non-Māori. Māori patients accounted for 36.8% of cases and had a significantly higher age-standardised incidence of AAS (6.9 vs 2.0 per 100,000 person

It's important to distinguish rosacea from the malar rash of lupus. Rosacea treatments are effective but should be started early, as late-stage rosacea (telangiectasias and rhinophyma) is expensive to treat cosmetically. Additionally, confusing the two risks undertreating lupus or overtreating rosacea. In his session at our Dermatology Update on Saturday May 16, Consultant Dermatologist Aaron Secrest offers a practical, pattern-based approach to determing which rash you are

Our latest selection of CPD options for you: Roadside testing, and Advance Care Planning WEBINAR 28 April: Join Anna Skinner on how the newly introduced roadside drug testing process works, and Jane Goodwin on how ACP supports meaningful conversations about values and preferences. Register here High-risk cutaneous squamous cell carcinoma (cSCC) WEBINAR 12 May: Rajan Patel discusses the importance of early detection and timely management of high-risk cSCC. Register here

Alopecia isn’t just cosmetic - it can be a marker of underlying disease and has meaningful emotional and quality-of-life consequences. In her session at our Dermatology Update on Saturday May 16, Consultant Dermatologist Cristina Mello, offers a practical, pattern-based approach to identifying common alopecia types, recognising red flags, initiating management, and knowing when to refer, with guidance on prognosis and patient counselling. Register now to secure your spot!

Prior studies have suggested aspirin lowers long-term cancer risk, especially colorectal cancer, but the ASPREE trial (Australia & US-based) in older adults found no reduction in cancer incidence and an unexpected rise in late-stage cancers and cancer mortality 1 . This study examined 10-year outcomes in more than 19,000 adults aged 70 and older from ASPREE and its observational extension. Participants received either low-dose aspirin (100mg) or a placebo. Over a median o

Our latest webinars and podcast for you: Whole of life protection: A focus on adult vaccination WEBINAR 14 April: Nikki Turner on the importance of adult immunisation as part of comprehensive preventive care in primary practice. Register here Redefining insomnia management WEBINAR 21 April: David Cunnington, a specialist sleep physician, will review contemporary insomnia management, including CBT-I, and discuss the role of medications, including lemborexant, a newer agent

This RCT 1 enrolled 437 secondary care patients aged ≥65 years (mean 75) with CHA₂DS₂-VASc scores ≥2 in men and ≥3 in women. Participants were assigned to 6-month (180-day) monitoring, using an Apple smartwatch with photoplethysmography and single-lead ECG functions, or to standard care. Over 6 months, atrial fibrillation (AF) was detected in 21 patients (9.6%) in the intervention group versus 5 (2.3%) in controls. Several asymptomatic AF episodes were identified only in th

Enhance your Dermatology Expertise: Join Our Online Session on Saturday, 16 May. Skin conditions are among the most frequent presentations in primary care. This 4-hour webinar brings together top New Zealand dermatology specialists to help you navigate these complexities with confidence. What to expect: Expert-led, primary care–focused updates on recognising and managing common dermatology presentations seen in everyday practice. Practical guidance on diagnosing and treating